Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-22-023152

Options or other derivatives

  • Director acquired 47,745 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Malik Fady Ibraham · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-06-13 Grant or award : show line 1 in the form Stock Option (Right to Buy) +47,745 $10.77 2032-06-13 47,745 47,745 D
Loading xslF345X03/form4.xml…